A study in this month's American Journal of Gastroenterology reports that IBD patients are at an increased risk of sustaining venous thromboembolic events.
Genetic polymorphisms within the vitamin D receptor and vitamin D deficiency are associated with chronic hepatitis C and poor response to interferon-alfa based therapy, finds the latest issue of the Journal of Hepatology.
A study in the most recent issue of the Journal of Hepatology investigates serum bilirubin and platelet count as part of a simple predictive model for survival in patients with refractory ascites treated by TIPS.
A study in May's issue of the Alimentary Pharmacology & Therapeutics investigates the significance of screening for JAK2V617F mutation in Budd–Chiari syndrome and portal venous system thrombosis.
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events, reports this month's issue of the Alimentary Pharmacology & Therapeutics.
A study in this week's issue of the Journal of the American Medical Association investigates the association of β-catenin alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
The latest issue of the Journal of the American Medical Association compares vitamin E or metformin with placebo in attaining the primary outcome of sustained reduction in alanine aminotransferase level in patients with pediatric NAFLD.
Thiopurine analogs may prevent relapse in quiescent IBD, however, there is a paucity of data for immunosuppressive therapy in IBD, reports the latest American Journal of Gastroenterology.
The most recent publication of Alimentary Pharmacology & Therapeutics investigates the treatment impact of certolizumab pegol and a daily practice composite score for the assessment of Crohn’s disease.
A study in May's issue of the Annals of Surgery reports increased local recurrence and reduced survival from colorectal cancer following anastomotic leak.
Anti-viral therapy has potential beneficial effects after the curative treatment of hepatitis B virus-related hepatocellular carcinoma in terms of tumor recurrence, liver-related mortality and overall survival, reports May's issue of the Alimentary Pharmacology & Therapeutics.
Improvements in hepatitis B virus treatment and uptake have most likely reduced non-hepatocellular carcinoma liver-related mortality, reports the latest issue of the Journal of Hepatology.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .